WG
AGIO icon

Winton Group’s Agios Pharmaceuticals AGIO Stock Holding History

Winton Group’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,751
Closed -$456K – 1090
2025
Q4 		$456K Buy
16,751
+351
+2% +$12.3K 0.02% 654
2025
Q3 		$658K Buy
+16,400
New +$617K 0.02% 536
2023
Q2 		– Sell
-23,865
Closed -$548K – 761
2023
Q1 		$548K Buy
23,865
+2,435
+11% +$64.7K 0.03% 654
2022
Q4 		$602K Buy
21,430
+19
+0.1% +$535 0.04% 576
2022
Q3 		$606K Sell
21,411
-5,529
-21% -$148K 0.04% 584
2022
Q2 		$597K Buy
26,940
+4,802
+22% +$108K 0.03% 641
2022
Q1 		$644K Buy
22,138
+3,382
+18% +$103K 0.03% 608
2021
Q4 		$617K Sell
18,756
-11,756
-39% -$473K 0.04% 618
2021
Q3 		$1.41M Buy
30,512
+10,947
+56% +$529K 0.08% 335
2021
Q2 		$1.08M Buy
19,565
+4,765
+32% +$266K 0.06% 490
2021
Q1 		$764K Sell
14,800
-2,108
-12% -$104K 0.04% 623
2020
Q4 		$733K Sell
16,908
-36,441
-68% -$1.44M 0.05% 578
2020
Q3 		$1.87M Buy
53,349
+22,548
+73% +$988K 0.06% 561
2020
Q2 		$1.65M Buy
30,801
+24,923
+424% +$1.15M 0.04% 743
2020
Q1 		$209K Buy
+5,878
New +$272K 0.01% 1242
2019
Q4 		– Sell
-10,790
Closed -$350K – 1523
2019
Q3 		$350K Buy
+10,790
New +$447K ﹤0.01% 1219

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Winton Group's AGIO Position: Q1 2026 in Review

Winton Group sold out of Agios Pharmaceuticals (AGIO) in Q1 2026, closing a stake of 16,751 shares — an estimated $456K sold.

Winton Group first reported a position in AGIO in Q3 2019 and held it in 16 quarters. The position peaked at $1.87M in Q3 2020. 234 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Winton Group reported no remaining Agios Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Winton Group sold 16,751 Agios Pharmaceuticals shares in Q1 2026, an estimated $456K.
  • Winton Group first reported a position in Agios Pharmaceuticals in Q3 2019 and held it in 16 quarters.
  • Winton Group's Agios Pharmaceuticals position peaked at $1.87M in Q3 2020.
  • 234 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Winton Group's 13F filing for Q1 2026, filed 12 May 2026.